Filter
612
Filtered Results: 612
Text search:
Murray
C.
Featured
Recommendations
48
New Publications
97
Language
Document type
No document type
331
Studies & Reports
189
Guidelines
56
Manuals
21
Strategic & Response Plan
6
Fact sheets
3
Training Material
2
Infographics
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
38
India
19
Kenya
17
Latin America and the Carribbean
16
South Africa
12
Russia
11
Africa
10
Ethiopia
10
Ukraine
9
Sierra Leone
9
Western and Central Europe
9
Eastern Europe
9
Syria
8
Nigeria
8
Burkina Faso
7
Senegal
6
Guinea
6
Zambia
6
Liberia
6
Ghana
5
Tanzania
5
Nepal
4
Malawi
4
Congo, Democratic Republic of
4
Paraguay
4
Namibia
4
Mali
4
Benin
3
Rwanda
3
Chile
3
Haiti
3
Middle East and North Africa
3
Bangladesh
3
Uganda
3
Botswana
3
Colombia
2
China
2
Cameroon
2
Peru
2
Zimbabwe
2
Cambodia
2
Guinea-Bissau
2
Venezuela
2
Eastern Europe and Central Asia
2
North America
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Brazil
2
Yemen
2
Indonesia
2
Somalia
2
Madagascar
2
Pakistan
2
Lesotho
1
Togo
1
Canada
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Philippines
1
Mozambique
1
USA
1
Asia
1
Germany
1
West and Central Africa
1
Luxembourg
1
Japan
1
Belgium
1
France
1
Spain
1
East and Southern Africa
1
Southern Africa
1
Lebanon
1
Vietnam
1
Djibouti
1
Egypt
1
Sudan
1
South Sudan
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
145
Clinical Guidelines
48
Public Health
43
Women & Child Health
43
Key Resources
22
Capacity Building
9
Pharmacy & Technologies
1
Toolboxes
Mental Health
94
TB
61
Planetary Health
41
HIV
40
Health Financing Toolbox
29
NCDs
29
COVID-19
24
Disability
20
NTDs
18
Ebola & Marburg
15
AMR
15
Caregiver
14
Global Health Education
11
Natural Hazards
7
Social Ethics
7
Polio
6
Refugee
5
Conflict
5
Rapid Response
3
Pharmacy
3
Malaria
3
Specific Hazards
2
Cholera
1
Zika
1
A survival guide for clinicans.
3rd edition.
This policy brief aims to provide a review of the current progress on implementing the Burkina Faso national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implemen...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
A One Health Response. A Briefing Note
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
The Global Health Expenditure Report delves into the intricate landscape of global economies and health systems. This year, it focuses on health spending in 2022, the third year of the COVID-19 pandemic. It shows how countries around the world responded to the health and economic shocks of the pande...
This paper presents a bibliometric analysis of the literature on private health aid and official health assistance between 2000 and 2022. It provides an overview of the sites and themes in the literature pertaining to development assistance in health, and collates the significant policy recommendati...
In the last three decades, health financialization has surged in
several creative ways, yet this growing phenomenon remains surprisingly
unknown, and neglected, in the global health arena. Financialization in the
health domain could be described as the uncontrolled expansion of finance along vari...
Development assistance for health (DAH)
plays a vital role in supporting health programmes in lowand middle-income countries. While DAH has historically
focused on infectious diseases and maternal and child
health, there is a lack of comprehensive analysis of DAH
trends, strategic shifts and the...
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
Noncommunicable diseases (NCDs) (e.g., cardiovascular diseases, cancers, diabetes, and chronic respiratory diseases) and mental health conditions (e.g., Alzheimer’s disease and related dementias, depression, anxiety, autism spectrum disorders) are the world’s leading cause of preventable illness...
Las enfermedades no transmisibles (ENT) (por ejemplo, las enfermedades cardiovasculares, el cáncer, la diabetes y las enfermedades respiratorias crónicas) y los problemas de salud mental (por ejemplo, la enfermedad de Alzheimer y las demencias relacionadas, la depresión, la ansiedad y los trastor...
